AI Spotlight on ECR
Company Description
Ercros, S.A. manufactures and sells basic chemicals, intermediate chemicals, and pharmaceuticals in Spain.It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmacy.The Chlorine Derivatives segment produces ammonia, bioplastics, caustic potash and soda, chlorine, chloroisocyanurates, dicalcium phosphate, dichloroethane, hydrochloric acid, hydrogen peroxide, potassium carbonate, PVC compounds, sodium chlorate and chlorite, sodium hypochlorite, and vinyl chloride monomers.
This segment's products are used as intermediates in other industrial processes to purify and treat drinking and waste water; treat and maintain swimming pool water; bleach fabrics and paper; produce solvents, detergents, and strippers; manufacture printing inks and coloring; to produce compound feed and in cooling equipment.The Intermediate Chemicals segment provides formaldehyde, glues and resins, molding powders, paraformaldehyde, pentaerythritol and dipentaerythritol, and sodium formate for manufacturing chipboards, and decorative laminates and plywoods, as well as resins, paints, and varnishes in the furniture and decoration industry; plugs and switches in the electrical components sector; and household, sanitary, and packaging materials in the textile tanning industry.The Pharmacy division engages in the production of raw materials and intermediate products from antibiotic, cholesterol-lowering, anti-ulcer, and anti-fungal agents.
This segment's products include amlodipine besylate, azithromycin, clarithromycin, erythromycins, famotidine, calcium and sodium fosfomycin, fosfomycin trometamol, and fusidic acid.The company is also involved in exporting activities.Ercros, S.A. was founded in 1817 and is headquartered in Barcelona, Spain.
Market Data
Last Price | 3.54 |
Change Percentage | -0.28% |
Open | 3.54 |
Previous Close | 3.54 |
Market Cap ( Millions) | 323 |
Volume | 10994 |
Year High | 3.98 |
Year Low | 2.26 |
M A 50 | 3.54 |
M A 200 | 3.63 |
Financial Ratios
FCF Yield | 2.82% |
Dividend Yield | 2.72% |
ROE | 1.20% |
Debt / Equity | 45.05% |
Net Debt / EBIDTA | 361.62% |
Price To Book | 0.91 |
Price Earnings Ratio | 99.61 |
Price To FCF | 35.45 |
Price To sales | 0.4 |
EV / EBITDA | 13.76 |
News
- Jan -07 - Uncovering Opportunities: Ercros Among 3 Promising Penny Stocks
- Jan -03 - January 2025's Top Growth Companies With High Insider Confidence
- Dec -20 - 3 Stocks Estimated To Be Trading Up To 47% Below Intrinsic Value
- Dec -09 - Top Penny Stocks To Watch In December 2024
- Nov -18 - 3 Intriguing Stocks Estimated To Be Priced Below Fair Value By Up To 46.9%
- Oct -28 - Discover 3 Leading Growth Stocks With Strong Insider Ownership
Business Breakdown
Expected Mid-Term Growth
Segment n°1 -> Derivatives of Chlorine
Expected Growth : 0.8 %
What the company do ?
Derivatives of Chlorine from Ercros, S.A. include calcium hypochlorite, sodium hypochlorite, and chlorine tablets, used as disinfectants and sanitizers in water treatment, swimming pools, and industrial applications.
Why we expect these perspectives ?
The 0.8 growth rate of Derivatives of Chlorine from Ercros, S.A. is driven by increasing demand from the water treatment industry, expansion into emerging markets, and strategic partnerships. Additionally, investments in R&D have improved production efficiency, reducing costs and increasing competitiveness. These factors have contributed to the steady growth of the segment.
Segment n°2 -> Chemistry Intermediate
Expected Growth : 0.9 %
What the company do ?
Chemistry Intermediate from Ercros, S.A. is a Spanish-based company that produces and supplies a wide range of chemical intermediates for various industries.
Why we expect these perspectives ?
Ercros' Chemistry Intermediate segment growth of 0.9 is driven by increasing demand for specialty chemicals, expansion into new markets, and strategic partnerships. Additionally, the company's focus on R&D and process optimization has improved production efficiency, leading to higher volumes and revenue growth.
Segment n°3 -> Pharmacy
Expected Growth : 1.1 %
What the company do ?
Pharmacy from Ercros, S.A. is a Spanish pharmaceutical company that develops and manufactures active pharmaceutical ingredients and finished dosage forms.
Why we expect these perspectives ?
Ercros, S.A.'s Pharmacy segment growth of 1.1% is driven by increasing demand for generic and specialty medicines, expansion into new markets, and strategic partnerships. Additionally, investments in digitalization and e-commerce platforms enhance customer experience, contributing to moderate growth.
Ercros, S.A. Products
Product Range | What is it ? |
---|---|
Chlorine | Ercros, S.A. produces chlorine through the electrolysis of sodium chloride, used as a disinfectant, sanitizer, and oxidizing agent in various industries such as water treatment, paper bleaching, and pharmaceuticals. |
Caustic Soda | Ercros, S.A. produces caustic soda, also known as sodium hydroxide, used in various industries such as paper, textiles, and soap manufacturing, as well as in the production of detergents and cleaning products. |
Chlorine Derivatives | Ercros, S.A. produces a range of chlorine derivatives, including chloroform, carbon tetrachloride, and perchloroethylene, used in various applications such as pharmaceuticals, agrochemicals, and refrigerants. |
Intermediate Chemicals | Ercros, S.A. produces intermediate chemicals, including epichlorohydrin, used in the production of epoxy resins, and other specialty chemicals used in various industries. |
Pharmaceutical Intermediates | Ercros, S.A. produces pharmaceutical intermediates, including APIs (Active Pharmaceutical Ingredients) and other specialty chemicals used in the production of pharmaceuticals. |
Ercros, S.A.'s Porter Forces
Threat Of Substitutes
The threat of substitutes for Ercros, S.A. is medium due to the availability of alternative products in the market.
Bargaining Power Of Customers
The bargaining power of customers for Ercros, S.A. is high due to the concentration of customers in the market.
Bargaining Power Of Suppliers
The bargaining power of suppliers for Ercros, S.A. is low due to the availability of multiple suppliers in the market.
Threat Of New Entrants
The threat of new entrants for Ercros, S.A. is medium due to the moderate barriers to entry in the market.
Intensity Of Rivalry
The intensity of rivalry for Ercros, S.A. is high due to the high competition in the market.
Capital Structure
Value | |
---|---|
Debt Weight | 25.82% |
Debt Cost | 3.95% |
Equity Weight | 74.18% |
Equity Cost | 8.30% |
WACC | 7.17% |
Leverage | 34.80% |
Ercros, S.A. : Quality Control
Ercros, S.A. passed 3 out of 9 key points:
Historical Valuation
Price/Earnings Ratio
Margin Valuation
Peers Valuation
Competitors
Company | Rational |
---|---|
TESB.BR | Tessenderlo Group NV, together with its subsidiaries, engages in the agriculture, valorizing bio-residuals, energy, and industrial solution businesses worldwide. It operates through four segments: Agro, Bio-Valorization, Industrial Solutions, and T-Power. … |
PCE.WA | Grupa Azoty Zaklady Chemiczne Police S.A. manufactures and sells mineral fertilizers in Poland, Germany, South America, rest of Europe, and internationally. The company provides compound fertilizers, such as nitrogen, phosphorus, … |
RBT.PA | Robertet SA produces and sells perfumes, aromas, and natural products. The company operates in three segments: Raw materials, Fragrances, and Flavors. It also produces organic essential oils and active ingredients. … |
PCR.WA | PCC Rokita SA manufactures and distributes chemical products in Poland and internationally. The company offers chloralkali, raw materials, and intermediates; polyurethanes; specialty products; and surfactants products, as well as polyols, … |
ZAP.WA | Zaklady Azotowe Pulawy S.A. manufactures and sells fertilizer and chemical products worldwide. Its fertilizers include ammonium nitrate under the PULAN name; Pulan Macro, a white to beige granular fertilizer; urea-ammonium … |